Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$834M |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Amazon
AMZN
|
+$604M |
| 4 |
Meta Platforms (Facebook)
META
|
+$293M |
| 5 |
Johnson & Johnson
JNJ
|
+$263M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| 1 | Technology | 23.53% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2076
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $629K | ﹤0.01% |
165,500
| – | – |
|
2077
Matsons
MATX
$3.29B
| $628K | ﹤0.01% |
20,500
| – | – |
|
2078
World Acceptance Corp
WRLD
$900M
| $628K | ﹤0.01% |
11,500
-1,400
| -11% | -$76.5K |
|
|
PDLI
2079
DELISTED
PDL BioPharma, Inc.
PDLI
| $627K | ﹤0.01% |
222,400
| – | – |
|
|
ERF
2080
DELISTED
Enerplus Corporation
ERF
| $623K | ﹤0.01% |
431,455
-11,400
| -3% | -$16.5K |
|
2081
Astrana Health
ASTH
$1.38B
| $622K | ﹤0.01% |
48,144
| – | – |
|
2082
PDF Solutions
PDFS
$765M
| $619K | ﹤0.01% |
52,800
| – | – |
|
2083
Hackett Group
HCKT
$575M
| $618K | ﹤0.01% |
48,592
| – | – |
|
2084
Arcus Biosciences
RCUS
$1.23B
| $618K | ﹤0.01% |
44,500
+1,300
| +3% | +$18.1K |
|
|
SRG
2085
Seritage Growth Properties
SRG
$237M
| $618K | ﹤0.01% |
67,838
+900
| +1% | +$8.2K |
|
2086
Live Oak Bancshares
LOB
$1.67B
| $617K | ﹤0.01% |
49,500
+1,800
| +4% | +$22.4K |
|
2087
Mitek Systems
MITK
$467M
| $617K | ﹤0.01% |
78,300
+1,500
| +2% | +$11.8K |
|
2088
UroGen Pharma
URGN
$869M
| $615K | ﹤0.01% |
34,500
+500
| +1% | +$8.91K |
|
|
HUYA
2089
Huya Inc
HUYA
$780M
| $612K | ﹤0.01% |
36,100
| – | – |
|
2090
Kenon Holdings
KEN
$2.43B
| $612K | ﹤0.01% |
41,763
-3,419
| -8% | -$50.1K |
|
|
CNR
2091
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $611K | ﹤0.01% |
133,900
+1,700
| +1% | +$7.76K |
|
2092
G-III Apparel Group
GIII
$1.12B
| $606K | ﹤0.01% |
78,700
-900
| -1% | -$6.93K |
|
2093
First Mid Bancshares
FMBH
$945M
| $605K | ﹤0.01% |
25,500
| – | – |
|
2094
GameStop
GME
$11.2B
| $605K | ﹤0.01% |
691,128
| – | – |
|
2095
Tejon Ranch
TRC
$448M
| $604K | ﹤0.01% |
42,980
+800
| +2% | +$11.2K |
|
2096
Guess, Inc.
GES
$869M
| $603K | ﹤0.01% |
89,000
-7,000
| -7% | -$47.4K |
|
2097
The Bancorp
TBBK
$3.5B
| $603K | ﹤0.01% |
99,300
+1,600
| +2% | +$9.72K |
|
|
ALTA
2098
DELISTED
Altabancorp Common Stock
ALTA
| $602K | ﹤0.01% |
31,100
+500
| +2% | +$9.68K |
|
2099
Sonic Automotive
SAH
$2.73B
| $600K | ﹤0.01% |
45,200
+500
| +1% | +$6.64K |
|
2100
Mercantile Bank Corp
MBWM
$775M
| $599K | ﹤0.01% |
28,300
| – | – |
|